# Assessment of Remnant Liver Function in ALPPS by Gd-EOB-DTPA Enhanced MRI

> **NCT04559451** · — · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Liver Function Failure
- Liver Malignant Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04559451
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04559451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04559451, "Assessment of Remnant Liver Function in ALPPS by Gd-EOB-DTPA Enhanced MRI". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04559451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*